Skip to main content
. Author manuscript; available in PMC: 2020 Nov 20.
Published in final edited form as: Vaccine. 2020 Oct 22;38(49):7756–7763. doi: 10.1016/j.vaccine.2020.10.045

Figure 2. Log(prevalence ratios) from the carriage models for children under 5 in Israel, November 2009-June 2016.

Figure 2.

Log-transformed ratios comparing late post- to pre-vaccine prevalence (last year/first year) are shown for each serotype with 95% credible intervals from the Jewish (A) and Bedouin (B) carriage models. The serotypes are shown from highest to lowest log prevalence ratios.